Using dihydropyridine-release strategies to enhance load effects in engineered human bone constructs.

Mairead A Wood1, Ying Yang, Peter B M Thomas

  • 1Institute of Science and Technology in Medicine, Keele University, Stoke-on-Trent, United Kingdom.

Tissue Engineering
|September 26, 2006
PubMed
Summary

Novel biodegradable scaffolds deliver the calcium channel agonist Bay K8644 to enhance mechanical signaling for bone tissue engineering. This promotes osteoid production and mineralization, leading to stronger engineered bone tissue.

Related Concept Videos